Skip to main content

Young Teresa L.'s Form 4 filing

Seres Therapeutics, Inc. (MCRB) · filed Nov 18, 2025

Accession no.
0001193125-25-286236
Filed
Nov 18, 2025
Trade date
Nov 15, 2025
Filing delay
3 days
Rule 10b5-1 plan
Checked

This filing lists 4 non-derivative transactions and 3 derivative transactions. Open-market sales total $18.0K. It was filed 3 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Young Teresa L.CIK 0001814656Officer (See Remarks)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Nov 15, 2025Common StockMOption exerciseAcquired+3,998–F1–9,213Direct
Nov 15, 2025Common StockMOption exerciseAcquired+132–F1–9,345Direct
Nov 15, 2025Common StockMOption exerciseAcquired+98–F1–9,443Direct
Nov 15, 2025Common StockSSaleDisposed−1,042$17.30−$18,026.68,401Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Nov 15, 2025Common StockMOption exerciseDisposed−3,998$0.00$00Direct
Nov 15, 2025Common StockMOption exerciseDisposed−132$0.00$0664Direct
Nov 15, 2025Common StockMOption exerciseDisposed−98$0.00$0878Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock.

Referenced by the price of 3 transactions in Table I.

Remarks

EVP, Chief Commercial & Strategy Officer

Read the full filing on SEC EDGAR (opens in a new tab)